EGRX – eagle pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

EGRX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/19

01:00 pm

egrx

ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs

Neutral Report

ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs

Report

10/30

06:50 am

egrx

Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan

Neutral Report

Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan

Report

10/21

05:05 pm

egrx

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders [Yahoo! Finance]

Neutral Report

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders [Yahoo! Finance]

Report

10/21

04:05 pm

egrx

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders

Neutral Report

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders

Report

10/7

01:30 am

egrx

Eagle Pharmaceuticals GAAP EPS of -$3.88, revenue of $37.27M [Seeking Alpha]

Neutral Report

Eagle Pharmaceuticals GAAP EPS of -$3.88, revenue of $37.27M [Seeking Alpha]

Report

10/6

07:30 pm

egrx

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

Neutral Report

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

Report

9/17

04:43 pm

egrx

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Medium Report

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.